2023-508439-30-00CompletedPhase 1
Safety Study to Compare the Gastrointestinal Tolerability of Oral Tegomil Fumarate and Dimethyl Fumarate (Tecfidera®) in Healthy Volunteers.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 7 Mar 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 210 (actual)
- First submitted
- 7 Dec 2023
- Start date
- 21 Aug 2024
- Lead sponsor
- Neuraxpharm Pharmaceuticals S.L.
- EU CT number
- 2023-508439-30-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 210
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Blueclinical Investigacao E Desenvolvimento Em Saude Lda. | Porto | Portugal | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.